| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 03/12/2008 | EP1896411A2 Process for preparing renin inhibitors |
| 03/12/2008 | EP1896410A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 03/12/2008 | EP1896023A2 Chemokine receptor binding compounds |
| 03/12/2008 | EP1896021A1 Solid pharmaceutical preparation containing (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chroman |
| 03/12/2008 | EP1896014A2 Chemical compounds |
| 03/12/2008 | EP1708713B1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d)(1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system |
| 03/12/2008 | EP1656355B1 Piperazine derivatives and methods of use |
| 03/12/2008 | EP1560815B1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
| 03/12/2008 | EP1539693B1 Cannabinoid receptor agonists |
| 03/12/2008 | EP1461330B1 3H-NAPHTHO[2,1-b]-PYRANE DERIVATIVES AND THEIR USE |
| 03/12/2008 | EP1456657A4 Tagged microparticle compositions and methods |
| 03/12/2008 | CN101142209A Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 03/12/2008 | CN101142192A 1,2-diphenyl-imidazole derivatives and their use as CB1 receptor ligands |
| 03/12/2008 | CN101142185A Indoles useful in the treatment of inflammation |
| 03/12/2008 | CN101139345A Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 03/12/2008 | CN101139344A Method for extracting rohitukine |
| 03/12/2008 | CN101139340A N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines |
| 03/12/2008 | CN101139317A Organic semiconductor material containing carbazole unit and synthesis |
| 03/12/2008 | CN100374435C Substd. pyridines and pyridazines with angiogenesis inhibiting activity |
| 03/12/2008 | CN100374425C Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers |
| 03/12/2008 | CN100374424C Heterocyclic amide derivative and use as pesticide |
| 03/12/2008 | CN100374115C Substituted diketopiperazines as oxytocin antagonists |
| 03/11/2008 | US7342120 Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 03/11/2008 | US7342118 Imidazole compounds for the treatment of neurodegenerative disorders |
| 03/11/2008 | US7342115 Binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology |
| 03/11/2008 | US7342114 4-O esters such as thymin-1-yl alkyl ester; cancer; type II DNA topoisomerase inhibition, enzyme mediated production of lethal DNA strand breaks |
| 03/11/2008 | US7342027 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof |
| 03/11/2008 | US7342026 combining substituted quinolines with a carrier; leishmania/HIV infection; viricide, parasiticide |
| 03/11/2008 | US7342019 5, 6-diaryl-pyrazine-2-amide derivatives as CB1 antagonists |
| 03/11/2008 | US7341700 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 03/11/2008 | CA2485298C Substituted pyrazolyl compounds for the treatment of inflammation |
| 03/11/2008 | CA2340230C Pyridazinone derivatives having cell adhesion inhibiting activity |
| 03/11/2008 | CA2335104C Arylalkanoylpyridazines |
| 03/11/2008 | CA2293382C Piperazine derivatives and their use as anti-inflammatory agents |
| 03/11/2008 | CA2223535C 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
| 03/11/2008 | CA2192764C Integrin receptor antagonists |
| 03/06/2008 | WO2008027542A2 5-substituted isoindoline compounds |
| 03/06/2008 | WO2008027483A1 Benzofuran derivatives as modulators of the 5-ht2a receptor |
| 03/06/2008 | WO2008027081A1 Processes for the purification of (3r,4s)-4-(4-hydroxy-protected-phenyl)-1-(4-fluorophenyl)-3-(4-fluorophenyl)-3-oxopropyl] azetidin-2-one |
| 03/06/2008 | WO2008027073A1 Insecticidal n-substituted (heteroaryl)cycloalkyl sulfoximines |
| 03/06/2008 | WO2008026704A1 Isoquinoline derivative |
| 03/06/2008 | WO2008025886A1 Metal chelates and chelating agents containing triazolyl subunits |
| 03/06/2008 | WO2008025798A1 Pyridine compounds for treating gpr119 related disorders |
| 03/06/2008 | WO2008025735A1 Substituted oxindole derivatives and their use as vasopressin and/or oxytocin receptor ligands |
| 03/06/2008 | WO2008006499A8 Substituted furyl sulfonylamino(thio)carbonyl triazoline(thi)ones |
| 03/06/2008 | WO2007146225A3 Heterocyclic aspartyl protease inhibitors |
| 03/06/2008 | WO2007144129A3 Pyrrolidine derivatives useful against diseases that depends on activity of renin |
| 03/06/2008 | WO2007131201A3 Compounds and compositions as hedgehog pathway modulators |
| 03/06/2008 | WO2007117607A9 Quinazolines for pdk1 inhibition |
| 03/06/2008 | US20080058543 Process for making chiral 1,4-disubstituted piperazines |
| 03/06/2008 | US20080058525 Novel dye complexes and use thereof in imaging members and methods |
| 03/06/2008 | US20080058524 Novel dyes and use thereof in thermal imaging members and methods |
| 03/06/2008 | US20080058519 Quinazoline ditosylate salt compounds |
| 03/06/2008 | US20080058516 Epoxycarboxamide compound, azide compound, and amino alcohol compound, and process for preparing alpha-keto amide compound using them |
| 03/06/2008 | US20080058514 ceramide-like inhibitors; novel intermediates formed during the synthesis; Glycosphingolipids |
| 03/06/2008 | US20080058386 1-(4-Methoxy-benzenesulfonyl)-2,3-dihydro-1H-indol-7-ylamine; inhibiting tubulin polymerization; anticarcinogenic; mitotic arrest of microtubule structure, neovascularization; angiogenesis inhibitor: atherosclerosis, rheumatoid arthritis or Crohn's disease, diabetic retinopathy, psoriasis |
| 03/06/2008 | US20080058383 Such as 2-methyl-2-(4-nitro-3-trifluoromethyl-phenylamino)-propan-1-ol; prostate cancer; cardiovascular disorders; psychological disorders |
| 03/06/2008 | US20080058376 Useful in treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels; treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels; neuropathic pain |
| 03/06/2008 | US20080058372 2,5-bis{[alkyl(or aryl)imino]aminophenyl}furans and thiophenes; "reversed" amidines; DNA-binding affinities; microbiocide; mycobacterial, fungal, protozoal infection; Mycobacterium tuberculosis, Trypanosoma spp., Candida albicans, Aspergillus spp., Cryptosporidium parvum, Giardia lamblia, Plasmodium spp. |
| 03/06/2008 | US20080058359 1-[[3-[(1,4,5,6-Tetrahydro-2-pyrimidinyl)amino]phenyl]acetyl]-4-piperidinepropanoic acid; new class of selective modulator of beta 3, beta 5 or dual integrin receptors; anticarcinogenic, antiinflammatory, antidiabetic agent |
| 03/06/2008 | US20080058356 2,6 Bisheteroaryl-4-Aminopyrimidines as Adenosine Receptor Antagonists |
| 03/06/2008 | US20080058334 Dermatological or oncological disorders; N-(4-fluorophenyl)-N'-[4-[1-(1H-imidazol-1-yl)-2-methylpropyl]phenyl]urea for example |
| 03/06/2008 | US20080058311 Antagonizing N-type calcium channels; use as analgesic, neurodegenerative diseases, brain injury, bronchial asthma, unstable angina and irritable colitis, drug withdrawal symptoms; t-butyl 2-[4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-piperidinyl]-2-oxoethylcarbamate for example |
| 03/06/2008 | US20080058304 Inhibitors of UPD-3-O (R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase, an enzyme present in gram negative bacteria; azetidine, pyrrolidine, or 3-pyrroline 2-carboxylic acid hydroxyamides; 1-(3,4-dimethoxy-5-propylbenzoyl)pyrrolidine-2R-carboxylic acid hydroxyamide for example |
| 03/06/2008 | CA2670271A1 Substituted oxindole derivatives, medicinal products containing them, and use thereof |
| 03/06/2008 | CA2661480A1 Insecticidal n-substituted (heteroaryl)cycloalkyl sulfoximines |
| 03/06/2008 | CA2660806A1 5-substituted isoindoline compounds |
| 03/06/2008 | CA2660699A1 Pyridine compounds for treating gpr119 related disorders |
| 03/05/2008 | EP1894921A2 9, 10-Alpha, Alpha-Oh-Taxane analogs and methods for production thereof |
| 03/05/2008 | EP1893598A1 Alkylquinoline and alkylquinazoline kinase modulators |
| 03/05/2008 | EP1893588A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 03/05/2008 | EP1893577A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 03/05/2008 | EP1893576A1 Treatment of protein folding disorders |
| 03/05/2008 | EP1893574A2 Peptide deformylase (pdf) inhibitors 4 |
| 03/05/2008 | EP1893571A2 Process for production of 4-biphenylyazetidin-2-ones |
| 03/05/2008 | EP1893197A1 Chromane substituted benzimidazole derivatives as acid pump antagonists |
| 03/05/2008 | EP1713797B1 1-isopropyl-2-oxo-1,2-dihydropyridine-3-carboxamide derivatives having 5-ht4 receptor agonistic activity |
| 03/05/2008 | EP1633748B1 Quinoline derivatives as phosphodiesterase inhibitors |
| 03/05/2008 | EP1560811B9 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 03/05/2008 | EP1045836B1 Pyridones as src family sh2 domain inhibitors |
| 03/05/2008 | CN101137652A Pyrimidine compounds having tie2 (tek) inhibitory activity |
| 03/05/2008 | CN101137648A Crystalline and amorphous 4-cyano-n-{(2r)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin -1-yl]-propyl}-n-pyridin-2-yl-benzamide hydrochloride |
| 03/05/2008 | CN101137647A Synthesis of himbacine analogs |
| 03/05/2008 | CN101137645A Aryl piperazine derivatives for the treatment of neuropsychiatric disorders |
| 03/05/2008 | CN101137638A Substituted aminoalkyl- and amidoalkyl-benzopyran derivatives |
| 03/05/2008 | CN101137636A Exo-selective synthesis of himbacine analogs |
| 03/05/2008 | CN101137622A Substituted gamma lactams as therapeutic agents |
| 03/05/2008 | CN100372840C Intermediate for the preparation of epimino |
| 03/05/2008 | CN100372838C Piperidine-benzenesulfonamide derivatives |
| 03/05/2008 | CN100372532C Imidazolin-2-ylaminophenyl amides as IP antagonists. |
| 03/04/2008 | US7339061 3-(4-oxo-4H-chromen-2-yl)-(1H)-quinolin-4-one derivatives, method for preparing same and pharmaceutical compositions containing same |
| 03/04/2008 | US7339059 Benzofuran-2-yl-carbonyl- and indol-2-yl-carbonyl-trans-2,5-dimethyl-piperazine derivatives; rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, inflammatory bowel disease, asthma; inhibit the interaction between inflammatory chemokines and their receptor |
| 03/04/2008 | US7339045 High affinity for streptavidin/avidin; biotinyl moiety linked to a photoreactive group covalently bound to substrate (proteins, peptides, amino acids, lipids, cells, virus particles, fatty acids, polysaccharides) |
| 03/04/2008 | US7338965 Enzyme inhibitors of beta-secretase which cleaves amyloid precursor protein present in Alzheimer's disease; Trisomy 21 (Down's Syndrome); Hereditary Cerebral Hemorrhage; cognition activators; Parkinson's disease |
| 03/04/2008 | US7338959 N2-isopropyl-N5,1-dimethyl-N5-[2-({4-[(methylsulfonyl)methyl]phenyl}amino)pyrimidin-4-yl]-1H-benzimidazole-2,5-diamine; vascular endothelial growth factor (VEGF) receptor-2 and tyrosine kinase containing Ig and EGF homology domains (TIE) -2 inhibitor; antiproliferation and antihypoxic agent |
| 03/04/2008 | US7338951 N-{2-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-morpholin-4-yl-pyridin-4-yl}-N'-(1 H-indol-3-ylmethylene)-hydrazine; interleukin IL-12 overproduction-related disorder; antiinflammatory agent; autoimmune diseases: multiple sclerosis, sepsis, neuropathies, cirrhosis, hepatitis, diabetes, arthritis |
| 03/04/2008 | US7338950 Amide compounds as ion channel ligands and uses thereof |
| 03/04/2008 | US7338947 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
| 03/04/2008 | US7338720 Organic electroluminescent element |
| 02/28/2008 | WO2008024974A1 Pyrimidine and pyrazine derivatives |